BDBM50327093 1-(2-Chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrim idin-4-yl]oxy}phenyl)-3-[3-(trifluoromethyl)phenyl]urea::CHEMBL1253916

SMILES OCCn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)c(Cl)c3)c12

InChI Key InChIKey=BJDIZSHPDXCEFW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50327093   

TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50327093(1-(2-Chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-...)
Affinity DataIC50:  4nMAssay Description:Inhibition of His-tagged human VEGFR2 expressed in Sf9 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50327093(1-(2-Chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of His-tagged human FGFR1 expressed in Sf9 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed